350 filings
Page 11 of 18
8-K
z2o29zg2ucereit szk
8 Jul 13
NanoViricides Signs Agreement with Public Health England for Testing of Various NanoViricides Against Specific Viruses of Current Concern
12:00am
8-K
abs9o2q
27 Jun 13
Departure of Directors or Certain Officers
12:00am
8-K
v225sa
31 May 13
Departure of Directors or Certain Officers
12:00am
8-K
0ve7dt
28 Feb 13
Entry into a Material Definitive Agreement
12:00am
D
i1q3onz0k8ig jwf
4 Feb 13
$6M in debt / options / securities to be acquired, sold $6M, 4 investors
12:00am
8-K
335fad1
1 Feb 13
Entry into a Material Definitive Agreement
12:00am
8-K
zl4tw 7ds2y
27 Dec 12
NanoViricides Announces Completion of Previously Reported $5 Million in Shelf Offering - Company Reports Having More Than Two Years of Cash on Hand
12:00am
424B5
0uruil8
27 Dec 12
Prospectus supplement for primary offering
12:00am
EFFECT
v5m4dcvaa8mpqas
21 Dec 12
Notice of effectiveness
12:00am
CORRESP
4hj 7eq7n
20 Dec 12
Correspondence with SEC
12:00am
CORRESP
begc7o2o
20 Dec 12
Correspondence with SEC
12:00am
DEF 14A
2mt v4r1z39cr
4 Dec 12
Definitive proxy
12:00am
NT 10-Q
53ljp1wdpr by
14 Nov 12
Notice of late quarterly filing
12:00am
UPLOAD
y8s0z4ovbzul4 bca
5 Nov 12
Letter from SEC
12:00am